FMP
NASDAQ
1 USD
-0.029999971 (-3%)
Mr. Yaky Yanay
Healthcare
Biotechnology
https://www.pluristem.com
NASDAQ
Pluristem Therapeutics Inc. operates as a bio-technology company. It focuses on the research, development, clinical trial, and manufacture of cell therapeutic products and related technologies for the treatment of various ischemic, inflammatory, and hematologic conditions, as well as autoimmune disorders. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trial for the recovery after surgery for hip fracture; in Phase II clinical trail for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also d...
0001158780
US72940R3003
72940R300
Matam Advanced Technology Park...
972747107171
IL
153
Dec 10, 2007
0001158780
NASDAQ
Biotechnology
Healthcare
72940R300
US72940R3003
IL
1
1.91
0
40.85M
-
-
2.11
-
-
-
-
-0.68
-
https://www.pluristem.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.